-
Paris school aide tried for alleged sexual assault of preschoolers
-
Pilgrims pray on Mount Arafat as hajj reaches peak
-
Rubio opens talks in Armenia on US cooperation
-
Senegal parliament elects ousted PM as speaker
-
Saudi Arabia turns to drones to shield pilgrims from extreme heat
-
Appeals court to review UK judge sparing teen rapists jail
-
Dominant Sabalenka moves into Roland Garros second round
-
Mango founder's son says accusation he killed his father 'unfounded'
-
'Curious' dolphin charms French town but experts concerned
-
MEXC Deploys 1,000 BTC to Strategic Reserves in March–April Security Report
-
Four dead after train hits school bus in Belgium
-
Ferrari unveils 'Luce', its first fully electric car, in a tough market
-
IS-linked women, children return to Australia
-
More climate records under threat as spring heatwave bakes western Europe
-
Brazil hope Ancelotti is the man to deliver their sixth World Cup
-
USA with all to prove in World Cup Group D
-
After AFCON drama, Morocco head to World Cup with big ambitions
-
Asia stocks fall, oil prices mixed on US-Iran deal uncertainty
-
Au so chic: Paris Mint to issue first solid-gold coins in a century
-
Ferrari unveils first fully electric car
-
Rubio revives 'Quad' with new Asia projects after questions on US
-
'Next time I'll stab you': Russia sees spate of wartime school attacks
-
Starbucks Korea reveals series of mishaps leading to 'Tank Day' campaign
-
Rubio revives 'Quad' alliance in India, but staying power unclear
-
Rubio says US ready to mediate as Moscow steps up Kyiv threats
-
Arsenal must banish European final demons to make Champions League history
-
Asia stocks, oil prices mixed on US-Iran deal uncertainty
-
Knicks sweep Cavs to reach first NBA Finals since 1999
-
Sonny Rollins, last jazz 'colossus,' dead at 95
-
Miserly Arsenal face PSG firepower in Champions League style clash
-
Brazil's World Cup challenge faces Morocco test in Group C
-
Panatta hopes Sinner can overcome 50 years of history at Roland Garros
-
'I think twice': Minorities fear World Cup immigration enforcement
-
Son of Libya's Haftar vows to make up for 'lost years' under Gaddafi
-
Cleaning the chakras of Ecuador's cats and dogs
-
Chile's once-dirty Mapocho river enjoys new lease on life
-
Rubio to revive 'Quad' alliance in India, but staying power unclear
-
War-hardened Kyiv residents return to routine after Russian strikes
-
US attacks missile sites in Iran, despite ceasefire
-
Fortun Holdings Announces Redesigned Fortun Funding Website and Launch Of 1-833-Funding
-
Champion Safe and West Coast Safes Go All-In for the Final Days of the LA County Fair
-
Agassi Sports Entertainment Files Application for NASDAQ Capital Market Listing
-
In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides
-
ELEKTROS Inc. Celebrates Growing Global Momentum as Investor Awareness Expands Across the Microcap Market
-
ReElement Technologies Achieves Historic U.S.-Based Tungsten Separation and Purification Capability Critical to National Defense
-
Classover Enters into a Strategic Partnership with 1Legion to Deploy up to $50 Million GPU Infrastructure
-
Worksport (NASDAQ:WKSP) Secures U.S. Patent For 'Industry-First' Zerofrost Heat Pump Through Its Subsidiary, Terravis Energy
-
AGRI-DYNAMICS, INC., Elaborates On The Company's Reorganization To Strengthen Its Future
-
Wellgistics Health Completes Reverse Split
-
Ameriwest Critical Metals Provides Q2 2026 Corporate Update and Announces Live CEO Investor Webinar
Yunu Launches De-ID & Export to Simplify Site-to-Sponsor Trial Data Sharing
New Capabilities Help Sites Anonymize and Export Trial Images and Results With Greater Control, Stronger Traceability, and Less Manual Effort
CARY, NC / ACCESS Newswire / May 26, 2026 / Yunu today announced De-ID & Export, a new add-on capability designed to give sites a streamlined way to anonymize and export trial images and results directly from their existing workflow.
For many research teams, retrieving and sharing trial data still depends on inefficient PACS retrieval workflows, disconnected downloads, separate anonymization steps, and repeated handoffs between sites and sponsors. The result is burdensome, manual work with weak traceability that slows trial execution when teams are forced to sift through images and prepare data by hand.
Yunu's De-ID & Export capability organizes the workflow, making the process easier.
Built within the Yunu platform, De-ID & Export gives sites a more controlled, technology-forward way to export trial images and results, apply optional trial-specific de-identification, and manage data access through role-based permissions. De-ID & Export supports trial, patient, and timepoint-level workflows. It includes trial images, results, and attachments, while Subject ID mapping helps support privacy and traceability across site-to-sponsor data handoff.
"Sites have shared that anonymizing and exporting trial imaging are some of the hardest and most frustrating parts of delivering data to sponsors," said Gordon Harris, Co-founder & Chief Science Officer of Yunu. "Our team is made up of trial veterans who understand these problems firsthand. Yunu is designed to simplify these types of complex challenges that have been the bane of trial programs for years. What once took weeks can now be done in minutes, with stronger control and less operational friction."
Ahead of its official release, Yunu's De-ID & Export has already been exceptionally well received and actively adopted by leading cancer centers. While designed to help teams reduce repetitive work and improve data delivery, the new capability more broadly reflects Yunu's view that source data from clinical trial imaging is central to many trial decisions and should be shared through collaborative real-time workflows that make data more accessible and actionable for the teams who depend on it.
Organizations interested in learning more about De-ID & Export can contact Yunu directly.
Yunu will be exhibiting at the American Society of Clinical Oncology's (ASCO) Annual Meeting this weekend, from Saturday, May 30th, to Monday, June 1st, at Booth #37115. Visit Yunu at ASCO or connect with the team by visiting yunu.io/contact-us.
About Yunu
Yunu is a clinical trial imaging platform that helps connect imaging workflows, data quality, and trial oversight across research sites and sponsors. By streamlining imaging operations and improving access to trial data, Yunu supports more efficient and compliant clinical trial execution.
Contact:
Lindsay Fleming
Chief Marketing Officer
[email protected]
SOURCE: Yunu
View the original press release on ACCESS Newswire
B.Finley--AMWN